Patent details
EP2043659 Title: ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT
Basic Information
- Publication number:
- EP2043659
- PCT Application Number:
- PCT/IL/2007/000836
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP077668663
- PCT Publication Number:
- WO/2008/004231
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT
- French Title of Invention:
- TRAITEMENT ANTICANCÉREUX FAISANT APPEL À UN H2-BLOQUANT, À AU MOINS UN AGENT ANTI-INFLAMMATOIRE ET À UN AGENT CYTOTOXIQUE
- German Title of Invention:
- BEHANDLUNG GEGEN KREBS MIT EINEM H2-BLOCKER, MINDESTENS EINEM ENTZÜNDUNGSHEMMENDEN MITTEL UND EINEM ZYTOTOXISCHEN MITTEL
- SPC Number:
Dates
- Filing date:
- 04/07/2007
- Grant date:
- 03/04/2013
- EP Publication Date:
- 03/04/2013
- PCT Publication Date:
- 10/01/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/04/2009
- EP B1 Publication Date:
- 03/04/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 04/07/2013
- Expiration date:
- 04/07/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 04/07/2007
- Name:
- Tiltan Pharma Ltd
- Address:
- 1-1 Hi-Tech Village Edmond Safra Campus Givat Ram P.O.B., 91390 Jerusalem, Israel (IL)
Inventor
- Name:
- BEN-SASSON Shmuel
- Address:
- Israel (IL)
Priority
1
- Priority Number:
- 819164 P
- Priority Date:
- 07/07/2006
- Priority Country:
- United States (US)
2
- Priority Number:
- 880107 P
- Priority Date:
- 12/01/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/675;
| Filing date | Document type | Number of pages |
|---|